Related references
Note: Only part of the references are listed.A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)
Marketa Kovalova et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2023)
A patent review of selective CDK9 inhibitors in treating cancer
Tizhi Wu et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2023)
Lights and Shadows on the Cancer Multi-Target Inhibitor Rigosertib (ON-01910.Na)
Ana Monfort-Vengut et al.
PHARMACEUTICS (2023)
Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum
John M. Bennett et al.
ACS Infectious Diseases (2023)
A single inhibitor for all KRAS mutations
Ryan B. Corcoran
NATURE CANCER (2023)
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome
Ioanna Deni et al.
CELL CHEMICAL BIOLOGY (2023)
Exploration of BAY 11-7082 as a Potential Antibiotic
Victoria E. Coles et al.
ACS INFECTIOUS DISEASES (2022)
Antibacterial activity evaluation of vinyl sulfones against global predominant methicillin-resistant Staphylococcus aureus USA300
Onanong Vorasin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)
Recent applications of vinyl sulfone motif in drug design and discovery
Reza Ahmadi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors
Laszlo Petri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
(E)-β-Trifluoromethyl vinylsulfones as antitumor agents: Synthesis and biological evaluations
Jun Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
The importance of sulfur-containing motifs in drug design and discovery
Muhamad Mustafa et al.
EXPERT OPINION ON DRUG DISCOVERY (2022)
High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine
Judith Straimer et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
The Ascension of Targeted Covalent Inhibitors
Juswinder Singh
JOURNAL OF MEDICINAL CHEMISTRY (2022)
A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
Sibel Suzen et al.
PHARMACEUTICALS (2022)
Design, synthesis and biological evaluation of phenyl vinyl sulfone based NLRP3 inflammasome inhibitors
Xiangna Zhang et al.
BIOORGANIC CHEMISTRY (2022)
The current state of the art and future trends in RAS-targeted cancer therapies
Salman R. Punekar et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Advances in covalent drug discovery
Lydia Boike et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Development of on-DNA vinyl sulfone synthesis for DNA-encoded chemical libraries
Yuting Gao et al.
ORGANIC CHEMISTRY FRONTIERS (2022)
Targeting CDK4 and CDK6 in cancer
Shom Goel et al.
NATURE REVIEWS CANCER (2022)
Microtubule associated proteins as targets for anticancer drug development
Sadiya Khwaja et al.
BIOORGANIC CHEMISTRY (2021)
Identification of highly selective covalent inhibitors by phage display
Shiyu Chen et al.
NATURE BIOTECHNOLOGY (2021)
Generation of potent Nrf2 activators via tuning the electrophilicity and steric hindrance of vinyl sulfones for neuroprotection
Zi-Long Song et al.
BIOORGANIC CHEMISTRY (2021)
Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease
Ji Won Choi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells
Drake M. Mellott et al.
ACS CHEMICAL BIOLOGY (2021)
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana et al.
LANCET INFECTIOUS DISEASES (2021)
Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
Thitinan Aiebchun et al.
MOLECULES (2021)
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Trends in kinase drug discovery: targets, indications and inhibitor design
Misty M. Attwood et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Mikah S. Brandes et al.
ASN NEURO (2020)
Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine
Guangyan Du et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities
Huaisheng Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Angel Cores et al.
BIOMOLECULES (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
Vinyl Sulfone-Based Inhibitors of Nonstructural Protein 2 Block the Replication of Venezuelan Equine Encephalitis Virus
Huaisheng Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics
Hao Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site
Wenlong Li et al.
BIOORGANIC CHEMISTRY (2019)
Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability
Ying Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Antioxidant, Anti-inflammatory, and Neuroprotective Effects of Novel Vinyl Sulfonate Compounds as Nrf2 Activator
Ji Won Choi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections
Gao-Feng Zha et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Matthias Gehringer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy
Ji Won Choi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent
Huaisheng Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes
David S. Hewings et al.
NATURE COMMUNICATIONS (2018)
Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Kevin A. Scott et al.
TOPICS IN CURRENT CHEMISTRY (2018)
Discovery of novel vinyl sulfone derivatives as anti-tumor agents with microtubule polymerization inhibitory and vascular disrupting activities
Wenlong Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Vinyl Sulfone-Based Fluorogenic Probe Capable of Selective Labeling of PHGDH in Live Mammalian Cells
Sijun Pan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent
Marco Jost et al.
MOLECULAR CELL (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Lysine-Targeting Covalent Inhibitors
Jonathan Pettinger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivatives in vitro models of Parkinson's disease
Xianling Ning et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Targeted Covalent Inhibitors for Drug Design
Thomas A. Baillie
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Synthesis and biological evaluation of heteroaryl styryl sulfone derivatives as anticancer agents
Yi Long et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
Sai Krishna Athuluri-Divakar et al.
CELL (2016)
Structure- and function-based design of Plasmodium-selective proteasome inhibitors
Hao Li et al.
NATURE (2016)
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Jonathan M. L. Ostrem et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-L-lysine as an amine nucleophile
Upendra P. Dahal et al.
MEDCHEMCOMM (2016)
ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines
Anil Prasad et al.
ONCOTARGET (2016)
Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets
Sonia Verma et al.
FRONTIERS IN PHARMACOLOGY (2016)
Safety, Efficacy, and Pharmacokinetic Profiles of Intravenous Rigosertib in Japanese Patients with Recurrent/Relapsed or Refractory Myelodysplastic Syndromes: A Multicenter, Open-Label Phase I Clinical Study
Michinori Ogura et al.
BLOOD (2016)
Recent advances in the synthesis of vinyl sulfones
Yuyu Fang et al.
RSC ADVANCES (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
Identification and Characterization of an Irreversible Inhibitor of CDK2
Elizabeth Anscombe et al.
CHEMISTRY & BIOLOGY (2015)
Design, Synthesis, and Biological Evaluation of Sulfonyl Acrylonitriles as Novel Inhibitors of Cancer Metastasis and Spread
Yi Shen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Oakley C. Olson et al.
NATURE REVIEWS CANCER (2015)
Design, Synthesis, and Biological Evaluation of (E)-3,4-Dihydroxystyryl Aralkyl Sulfones and Sulfoxides as Novel Multifunctional Neuroprotective Agents
Xianling Ning et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of (E)-3-((Styrylsulfonyl)methyl)pyridine and (E)-2-((Styrylsulfonyl)methyl)pyridine Derivatives as Anticancer Agents: Synthesis, Structure-Activity Relationships, and Biological Activities
Tiangong Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery of Vinyl Sulfones as a Novel Class of Neuroprotective Agents toward Parkinson's Disease Therapy
Seo Yeon Woo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury
Xianling Ning et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
An Endoperoxide-Based Hybrid Approach to Deliver Falcipain Inhibitors Inside Malaria Parasites
Rudi Oliveira et al.
CHEMMEDCHEM (2013)
Design, Synthesis, and Biological Evaluation of (E)-N-Aryl-2-arylethenesulfonamide Analogues as Potent and Orally Bioavailable Microtubule-Targeted Anticancer Agents
M. V. Ramana Reddy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
ON01210.Na (Ex-RAD®) Mitigates Radiation Damage through Activation of the AKT Pathway
Anthony D. Kang et al.
PLOS ONE (2013)
Relative reactivity and selectivity of vinyl sulfones and acrylates towards the thiol-Michael addition reaction and polymerization
Shunsuke Chatani et al.
POLYMER CHEMISTRY (2013)
Synthesis, antimicrobial and cytotoxic activities of sulfone linked bis heterocycles
A. Muralikrishna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design, synthesis and biological evaluation of novel (E)-α-benzylsulfonyl chalcone derivatives as potential BRAF inhibitors
Qing-Shan Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD® in mice
Sanchita P. Ghosh et al.
JOURNAL OF RADIATION RESEARCH (2012)
BAY 11-7082 Is a Broad-Spectrum Inhibitor with Anti-Inflammatory Activity against Multiple Targets
Jaehwi Lee et al.
MEDIATORS OF INFLAMMATION (2012)
Aza vinyl sulfones: Synthesis and evaluation as antiplasmodial agents
Paulo M. C. Gloria et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis and biological evaluation of benzyl styrylsulfonyl derivatives as potent anticancer mitotic inhibitors
Osama Chahrour et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Discovery of a Clinical Stage Multi-Kinase Inhibitor Sodium (E)-2-{2-Methoxy-5-[(2′,4′,6′-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): Synthesis, Structure-Activity Relationship, and Biological Activity
M. V. Ramana Reddy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
Christine Juliana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Vinyl sulfone: a versatile function for simple bioconjugation and immobilization
Julia Morales-Sanfrutos et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
Radiation Protection by a New Chemical Entity, Ex-Rad™: Efficacy and Mechanisms
Sanchita P. Ghosh et al.
RADIATION RESEARCH (2009)
Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents
M. V. Ramana Reddy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors
Roberta Ettari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection
Patricia S. Doyle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Vinyl sulfones: Synthetic preparations and medicinal chemistry applications
D. Christopber Meadows et al.
MEDICINAL RESEARCH REVIEWS (2006)
A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi
SC Barr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
K Gumireddy et al.
CANCER CELL (2005)
The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells
YJ Chen et al.
ANTI-CANCER DRUGS (2001)